We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
-14.47%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$5.96B
AUM Growth
-$2.66B
Cap. Flow
-$2.46B
Cap. Flow %
-41.33%
Top 10 Hldgs %
19.41%
Holding
1,586
New
385
Increased
156
Reduced
122
Closed
320

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.3M
2
DELL icon
Dell
DELL
+$42.5M
3
JD icon
JD.com
JD
+$38.9M
4
TSM icon
TSMC
TSM
+$32.4M
5
ACC
American Campus Communities, Inc.
ACC
+$31.6M

Sector Composition

Rank Sector Weight
1 Technology 20.75%
2 Financials 9.38%
3 Healthcare 5.16%
4 Consumer Discretionary 4.89%
5 Communication Services 4.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSIBW
1051
DELISTED
Tishman Speyer Innovation Corp. II Warrant
TSIBW
$98K ﹤0.01%
10,000
FSRDW
1052
DELISTED
Fast Radius, Inc. Warrants
FSRDW
$98K ﹤0.01%
155,521
RDBXW
1053
DELISTED
Redbox Entertainment Inc. Warrant
RDBXW
$91K ﹤0.01%
12,300
-543,396
-98% -$288K
KC
1054
Kingsoft Cloud Holdings
KC
$2.97B
$90K ﹤0.01%
+20,288
New +$86.8K
CBAY
1055
DELISTED
Cymabay Therapeutics
CBAY
$90K ﹤0.01%
+30,360
New +$72.5K
ACTG icon
1056
Acacia Research
ACTG
$447M
$88K ﹤0.01%
+17,487
New +$80.2K
CRXTW
1057
DELISTED
Clarus Therapeutics Holdings, Inc. Warrants
CRXTW
$88K ﹤0.01%
229,750
ENDP
1058
DELISTED
Endo International plc
ENDP
$87K ﹤0.01%
+187,886
New +$239K
MRNS
1059
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$85K ﹤0.01%
+17,565
New +$107K
VINC
1060
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$83K ﹤0.01%
3,147
+587
+23% +$26.1K
THWWW
1061
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
$83K ﹤0.01%
234,266
AGIL
1062
DELISTED
AgileThought Inc
AGIL
$83K ﹤0.01%
+15,997
New +$75.6K
MAPSW
1063
DELISTED
WM TECHNOLOGY INC WTS
MAPSW
$79K ﹤0.01%
24,097
-5,625
-19% -$7.61K
CARM
1064
DELISTED
Carisma Therapeutics
CARM
$78K ﹤0.01%
+4,787
New +$54.8K
DAVE icon
1065
Dave Inc
DAVE
$5.16B
$78K ﹤0.01%
+3,547
New +$344K
TNGX icon
1066
Tango Therapeutics
TNGX
$4.35B
$76K ﹤0.01%
16,675
-8,325
-33% -$50.4K
CIA icon
1067
Citizens
CIA
$248M
$75K ﹤0.01%
+17,805
New +$64.2K
MMAT
1068
DELISTED
Meta Materials Inc. Common Stock
MMAT
$74K ﹤0.01%
+723
New +$108K
SATL icon
1069
Satellogic
SATL
$525M
$73K ﹤0.01%
+17,742
New +$114K
MIST icon
1070
Milestone Pharmaceuticals
MIST
$141M
$72K ﹤0.01%
+11,732
New +$72.1K
SPIR.WS
1071
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
$72K ﹤0.01%
62,293
LCTX icon
1072
Lineage Cell Therapeutics
LCTX
$257M
$71K ﹤0.01%
+44,733
New +$59K
NMR icon
1073
Nomura Holdings
NMR
$28.6B
$71K ﹤0.01%
19,512
VKTX icon
1074
Viking Therapeutics
VKTX
$4.05B
$71K ﹤0.01%
+24,400
New +$60.4K
VSTM icon
1075
Verastem
VSTM
$534M
$71K ﹤0.01%
+5,124
New +$81.6K

Similar funds

LMR Partners's Q2 2022 Portfolio in Review

As of Q2 2022, LMR Partners held 1,586 positions worth $5.96B, down 31% from $8.61B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

LMR Partners withdrew a net $2.46B in Q2 2022, closing 320 positions and reducing 122 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $117M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

Against the trend, LMR Partners opened a new position in Microsoft worth $42.8M.

  • LMR Partners's largest Q2 2022 buy was Microsoft: 166,753 shares worth $42.8M.
  • LMR Partners added most to TSMC in Q2 2022, an estimated $32.4M increase.
  • LMR Partners's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $553M.
  • LMR Partners fully exited Invesco QQQ Trust in Q2 2022, selling an estimated $117M.
  • LMR Partners's ten largest holdings make up 19% of its $5.96B portfolio in Q2 2022.
  • LMR Partners opened 385 new positions and closed 320 in Q2 2022.
  • LMR Partners's portfolio value fell 31% quarter-over-quarter to $5.96B.

Based on LMR Partners's 13F filing for Q2 2022, filed 15 Aug 2022.